Bladder cancer
Results
Phase 2
This trial looked at different ways of treating early stage bladder cancer that had come back after initial treatment. It looked at surgery and a type of chemotherapy called mitomycin C.
It was for people with the most common type of bladder cancer called transitional cell cancer.
This trial was open for people to join between 2015 and 2017. These results were published in 2020.
Recruitment start: 28 January 2015
Recruitment end: 4 September 2017
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Mr Hugh Mostafid
Experimental Cancer Medicine Centre (ECMC)
The Institute of Cancer Research
NIHR Clinical Research Network: Cancer
NIHR Research for Patient Benefit (RfPB) programme
Last reviewed: 05 Oct 2017
CRUK internal database number: 12770
About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education
What to ask your doctor about clinical trials.
Meet and chat to other cancer people affected by cancer.
Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.
